WINNIE CHEN: Open Payments
NPI 1225603061 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,686 in 82 payments from 19 companies in 2025. Trend: 2023 $1,522 · 2024 $1,574 · 2025 $1,686
Food & beverage: $1,686
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $347 |
| Lilly USA, LLC | 14 | $259 |
| Astellas Pharma US Inc | 10 | $256 |
| Novo Nordisk Inc | 7 | $153 |
| Amgen Inc. | 9 | $137 |
| GlaxoSmithKline, LLC. | 6 | $131 |
| SANOFI-AVENTIS U.S. LLC | 4 | $98 |
| PFIZER INC. | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Paratek Pharmaceuticals, Inc. | 2 | $34 |
Products named: Veozah, AIRSUPRA, MOUNJARO, JARDIANCE, OTEZLA, BREZTRI, TZIELD, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
